Winthrop Advisory Group LLC lessened its stake in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 6.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,107 shares of the enterprise software provider’s stock after selling 354 shares during the quarter. Winthrop Advisory Group LLC’s holdings in Oracle were worth $1,117,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of ORCL. Vanguard Group Inc. boosted its holdings in shares of Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after buying an additional 3,513,464 shares during the period. Northern Trust Corp lifted its holdings in Oracle by 0.6% in the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider’s stock worth $2,760,048,000 after purchasing an additional 120,889 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Oracle by 0.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider’s stock valued at $1,941,195,000 after buying an additional 59,164 shares in the last quarter. Amundi lifted its holdings in Oracle by 3.3% in the 1st quarter. Amundi now owns 12,736,855 shares of the enterprise software provider’s stock valued at $1,749,280,000 after acquiring an additional 409,691 shares during the last quarter. Finally, Polen Capital Management LLC grew its position in Oracle by 17.6% in the first quarter. Polen Capital Management LLC now owns 12,609,101 shares of the enterprise software provider’s stock worth $1,762,878,000 after buying an additional 1,885,370 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Oracle in a report on Saturday, September 27th. Roth Capital reiterated a “hold” rating on shares of Oracle in a research note on Wednesday, June 18th. DA Davidson upped their price target on shares of Oracle from $220.00 to $300.00 and gave the company a “neutral” rating in a report on Wednesday, September 10th. BNP Paribas set a $377.00 price target on shares of Oracle in a report on Wednesday, September 10th. Finally, KeyCorp raised their target price on Oracle from $200.00 to $225.00 and gave the stock an “overweight” rating in a research report on Thursday, June 12th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Oracle currently has an average rating of “Moderate Buy” and a consensus target price of $304.71.
Insider Transactions at Oracle
In other Oracle news, Director William G. Parrett sold 11,500 shares of the firm’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the sale, the director owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This trade represents a 39.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the sale, the insider owned 132,656 shares in the company, valued at $42,603,800.96. This represents a 20.33% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 104,314 shares of company stock worth $31,272,223 over the last three months. Company insiders own 40.90% of the company’s stock.
Oracle Price Performance
NYSE ORCL opened at $284.46 on Wednesday. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The business has a 50 day simple moving average of $264.10 and a 200 day simple moving average of $207.36. The stock has a market cap of $810.94 billion, a price-to-earnings ratio of 65.85, a PEG ratio of 3.14 and a beta of 1.53.
Oracle (NYSE:ORCL – Get Free Report) last announced its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be paid a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle’s dividend payout ratio is 46.30%.
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also
- Five stocks we like better than Oracle
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- How to Short a Stock in 5 Easy Steps
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- High Flyers: 3 Natural Gas Stocks for March 2022
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.